Hot Life Science Investor Mandate 2: Chinese VC Firm Seeking to In-license Specific Technologies From Around the Globe

3 Sep

An approximately 200 million USD China based venture capital firm currently invests in healthcare (Pharmaceutical, medical device, diagnostics and Health IT) companies exclusively in China. In addition to investing in Chinese companies the firm is actively involved in and seeking to make new partnerships with technologies from around the globe in a number of specific technology areas exclusively for the Chinese market.

On the pharmaceutical end, the firm targets late stage assets post phase IIb to marketed products. For Medical technology products the firm currently holds companies that are looking for orthopedic products (spinal motion preservation and other non-fusion technologies), women’s health medical products, surgical instruments, dental devices and cardiovascular medical devices. On diagnostics, the primary focus is on oncology next generation sequencing systems and reagents; lastly for Health IT, diabetes management hardware.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: